Alert detail

LCD L38168: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — WPS

Policy ID: LCD-L38168Specialty: OncologyAdded: 9/12/2026Effective: March 6, 2025lcd
Routine

What changed

WPS finalizes liquid biopsy coverage rules for solid tumors in 6 states.

Who’s affected: Oncology billing teams · Effective: March 6, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 10 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.